Standard AOD-9604 Dosing Protocol Subcutaneous Injection Dosing: Beginner: 250 mcg per dose, once daily Intermediate: 300-400 mcg per dose, once daily or divided into two doses Advanced: 500 mcg per dose, once daily or 250 mcg twice daily Oral Administration Dosing (if using oral formulation): Standard: 1-2 mg per dose, once daily on empty stomach Higher protocols: Up to 5-10 mg daily, as studied in clinical trials Frequency: Once daily (morning preferred) or twice daily (morning and early afternoon) Timing: Best administered on an empty stomach, typically upon waking or before exercise Cycle Length: 12-16 weeks for initial assessment, with potential for longer protocols based on response Off Cycle: 4-8 weeks between cycles, though not strictly required based on current research Note: Start at the lower end of the dosing range to assess individual tolerance

Targeted expression of the signaling molecule decapentaplegic induces pattern duplications and growth alterations in Drosophila wings
& White, M
1 mg 6 units and 2 mg 12 units on a U-100 syringe
Best for most pressure ulcers, burns, surgical wounds, and ulcers
Storage and Handling : Proper storage conditions affect peptide stability and may influence the development of degradation products that could cause adverse reactions